Drug Shortage Report for TEVA-NARATRIPTAN
| Report ID | 128632 |
| Drug Identification Number | 02314290 |
| Brand name | TEVA-NARATRIPTAN |
| Common or Proper name | Naratriptan Tablets |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | NARATRIPTAN |
| Strength(s) | 1MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | P/PACK 8 |
| ATC code | N02CC |
| ATC description | ANTIMIGRAINE PREPARATIONS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2020-11-18 |
| Estimated end date | 2021-01-31 |
| Actual end date | 2021-01-20 |
| Shortage status | Resolved |
| Updated date | 2021-01-21 |
| Company comments | Product is short-dated, new product coming at end of 2020 |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2020-11-19 | English | Compare |
| v2 | 2020-11-19 | French | Compare |
| v3 | 2021-01-07 | English | Compare |
| v4 | 2021-01-07 | French | Compare |
| v5 | 2021-01-21 | English | Compare |
| v6 | 2021-01-21 | French | Compare |
Showing 1 to 6 of 6